Results 21 to 30 of about 95,919 (241)

Delayed viral clearance despite high number of activated T cells during the acute phase in Argentinean patients with hantavirus pulmonary syndrome. [PDF]

EBioMedicine, 2022
Iglesias AA, Períolo N, Bellomo CM, Lewis LC, Olivera CP, Anselmo CR, García M, Coelho RM, Alonso DO, Dighero-Kemp B, Sharma H, Kuhn JH, Di Paola N, Sanchez-Lockhart M, Palacios G, Schierloh LP, Martínez VP.   +16 more
europepmc   +2 more sources

Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model. [PDF]

Sci Rep, 2021
The use of antibody-based therapies for the treatment of high consequence viral pathogens has gained interest over the last fifteen years. Here, we sought to evaluate the use of unique camelid-based IgG antibodies to prevent lethal hantavirus pulmonary ...
Sroga P, Sloan A, Warner BM, Tierney K, Lew J, Liu G, Chan M, Deschambault Y, Stein DR, Soule G, Banadyga L, Falzarano D, Safronetz D.   +12 more
europepmc   +2 more sources

Emerging hantaviruses in Central Argentina: First case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay virus, and a novel orthohantavirus in Scapteromys aquaticus rodent. [PDF]

PLoS Negl Trop Dis, 2021
Orthohantaviruses are emerging rodent-borne pathogens that cause Hantavirus Pulmonary Syndrome in humans. They have a wide range of rodent reservoir hosts and are transmitted to humans through aerosolized viral particles generated by the excretions of ...
Bellomo C, Alonso DO, Ricardo T, Coelho R, Kehl S, Periolo N, Azogaray V, Casas N, Ottonelli M, Bergero LC, Cudós MC, Previtali MA, Martinez VP.   +12 more
europepmc   +2 more sources

Hantavirus Pulmonary Syndrome, Southern Chile

Emerging Infectious Diseases, 2003
We analyzed data from 25 consecutive patients with hantavirus pulmonary syndrome (HPS) admitted to the Puerto Montt and Osorno Regional Hospitals, southern Chile, from 1997 to 2001, emphasizing epidemiologic, clinical, radiographic, treatment, and ...
Raúl Riquelme, Mauricio Riquelme, Antoni Torres, Maria Luisa Rioseco, José Antonio Vergara, Luis Scholz, Andrea Carriel   +6 more
doaj   +4 more sources

Imported Fatal Hantavirus Pulmonary Syndrome

Emerging Infectious Diseases, 2007
To the Editor: Hantavirus pulmonary syndrome (HPS) is characterized by fever, gastrointestinal symptoms, respiratory distress, elevated hematocrit, hypoalbuminemia, and thrombocytopenia. Most cases in North America are acquired from rodent vectors and are caused by the Sin Nombre virus. Person-to-person transmission has been reported for Andes virus (1,
Steven Reynolds, Eleni Galanis, Mel Krajden, Muhammad Morshed, David Bowering, William Abelson, Tobias R. Kollmann   +6 more
doaj   +3 more sources

Hantavirus pulmonary syndrome outbreaks associated with climate variability in Northwestern Argentina, 1997-2017. [PDF]

PLoS Negl Trop Dis, 2020
Background Rodent-borne hantaviruses (genus Orthohantavirus) are the etiologic agents causing two human diseases: hemorrhagic fever with renal syndrome (HFRS) in Euroasia; and hantavirus pulmonary syndrome (HPS) in North and South America.
Ferro I, Bellomo CM, López W, Coelho R, Alonso D, Bruno A, Córdoba FE, Martinez VP.   +7 more
europepmc   +2 more sources

Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems [PDF]

Viruses
Hantaviruses, including the Sin Nombre virus (SNV) and Andes virus (ANDV), are associated with severe global health risks, causing high mortality rates in hantavirus pulmonary syndrome (HPS) patients.
Punya Shrivastava-Ranjan, Jamie A. Kelly, Laura K. McMullan, Deborah Cannon, Laura Morgan, Payel Chatterjee, Shilpi Jain, Joel M. Montgomery, Mike Flint, César G. Albariño, Christina F. Spiropoulou   +10 more
doaj   +2 more sources

Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Argentina, 2014. [PDF]

Emerg Infect Dis, 2020
Andes virus is unique among hantaviruses because it can be transmitted from person to person. This mechanism was previously supported by epidemiologic data and genetic evidence based only on partial sequences.
Alonso DO, Pérez-Sautu U, Bellomo CM, Prieto K, Iglesias A, Coelho R, Periolo N, Domenech I, Talmon G, Hansen R, Palacios G, Martinez VP.   +11 more
europepmc   +2 more sources

551: A COMPLEX CASE OF HANTAVIRUS PULMONARY SYNDROME AND HEMORRHAGIC FEVER WITH RENAL SYNDROME

Critical Care Medicine, 2023
Joseph Hennig, Jody Rosson, Karen Curry
openalex   +2 more sources

Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome. [PDF]

J Infect Dis, 2019
Background Hantavirus pulmonary syndrome (HPS) is caused by Andes virus (ANDV) and related hantaviruses in the Americas. Despite a fatality rate of 40%, the pathogenesis of HPS is poorly understood and factors associated with severity, fatality, and ...
Maleki KT, García M, Iglesias A, Alonso D, Ciancaglini M, Hammar U, Ljunggren HG, Schierloh P, Martínez VP, Klingström J.   +9 more
europepmc   +2 more sources